Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
UFPT 
UFP Technologies Inc (UFPT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: UFPT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $329.5
1 Year Target Price $329.5
| 1 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -5.82% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.51B USD | Price to earnings Ratio 22.69 | 1Y Target Price 329.5 |
Price to earnings Ratio 22.69 | 1Y Target Price 329.5 | ||
Volume (30-day avg) 4 | Beta 1.19 | 52 Weeks Range 178.26 - 354.22 | Updated Date 10/17/2025 |
52 Weeks Range 178.26 - 354.22 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 8.62 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.4% | Operating Margin (TTM) 16.45% |
Management Effectiveness
Return on Assets (TTM) 11.53% | Return on Equity (TTM) 19.29% |
Valuation
Trailing PE 22.69 | Forward PE 22.17 | Enterprise Value 1673413687 | Price to Sales(TTM) 2.56 |
Enterprise Value 1673413687 | Price to Sales(TTM) 2.56 | ||
Enterprise Value to Revenue 2.84 | Enterprise Value to EBITDA 14.86 | Shares Outstanding 7711126 | Shares Floating 7427434 |
Shares Outstanding 7711126 | Shares Floating 7427434 | ||
Percent Insiders 3.69 | Percent Institutions 119.15 |
Upturn AI SWOT
UFP Technologies Inc
Company Overview
History and Background
UFP Technologies, Inc. was founded in 1963. It has evolved from a foam fabricator to a designer and manufacturer of custom-engineered solutions utilizing foams, plastics, composites, and natural fiber materials.
Core Business Areas
- Medical: Provides custom solutions for medical devices and packaging, including single-use instruments and orthopedic soft goods.
- Defense: Offers protective solutions for military personnel and equipment, including armor and protective gear.
- Industrial: Creates custom components and packaging for various industrial applications, such as automotive, aerospace, and electronics.
- Consumer: Develops products for consumer goods applications, including athletic padding and recreational equipment.
Leadership and Structure
Jeffrey Bailly is the Chairman, President, and CEO. The company operates with a functional organizational structure, with departments focused on engineering, manufacturing, sales, and finance.
Top Products and Market Share
Key Offerings
- Medical Packaging: Custom-designed packaging solutions for medical devices, ensuring sterility and protection. Competitors include Amcor, Berry Global, and West Pharmaceutical Services. Market share data not readily available.
- Protective Armor: Lightweight body armor and vehicle armor solutions for military and law enforcement. Competitors include BAE Systems, and Textron Systems. Market share data not readily available.
- Specialty Foam Products: Custom engineered foam products used in packaging, protective gear, and consumer products. Competitors include Rogers Corporation, Armacell. Market share data not readily available.
Market Dynamics
Industry Overview
The market for engineered materials and packaging solutions is competitive and growing, driven by demand from the medical, defense, and industrial sectors. Regulatory requirements and technological advancements are key factors.
Positioning
UFP Technologies positions itself as a provider of custom-engineered solutions, differentiating itself through its design and engineering capabilities. It focuses on niche markets with specialized requirements.
Total Addressable Market (TAM)
TAM is estimated to be in the billions of dollars across the industries served. UFP Technologies focuses on specific segments, capturing a portion of this large market.
Upturn SWOT Analysis
Strengths
- Strong engineering and design capabilities
- Diversified customer base across multiple industries
- Focus on custom solutions
- Long-standing relationships with key customers
Weaknesses
- Reliance on key customers
- Potential for fluctuations in raw material costs
- Limited brand recognition compared to larger competitors
Opportunities
- Expanding into new geographic markets
- Developing new materials and technologies
- Acquiring smaller competitors
- Benefiting from increased outsourcing by OEMs
Threats
- Economic downturns impacting demand in key industries
- Increased competition from low-cost manufacturers
- Changes in regulatory requirements
- Disruptions in supply chains
Competitors and Market Share
Key Competitors
- Rogers Corporation (ROG)
- Armacell (No US stock Symbol)
- Poron (ROG Product)
Competitive Landscape
UFP Technologies competes based on its engineering capabilities, custom solutions, and focus on niche markets. Its competitive advantage lies in its ability to provide tailored solutions to its customers.
Major Acquisitions
AccuMED Innovative Technologies
- Year: 2016
- Acquisition Price (USD millions): 30.5
- Strategic Rationale: Expansion of medical product capabilities and market share.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by organic growth and acquisitions. Check SEC filings for accurate data.
Future Projections: Future growth projections would require analyst estimates and company guidance. This information is typically available from financial news sources.
Recent Initiatives: Recent strategic initiatives may include acquisitions, new product launches, and expansion into new markets.
Summary
UFP Technologies is a player in custom-engineered solutions with a diversified portfolio, particularly in medical and defense. It is working well in expanding its product capabilities through strategic acquisitions. The company needs to keep an eye on raw materials costs and emerging competition. It should also focus on expanding its presence in growth markets and reduce reliance on a few key customers.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Financial News Sources
Disclaimers:
This analysis is based on available public information and does not constitute financial advice. Market share data is estimated and may not be precise. Refer to official company documents for accurate information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About UFP Technologies Inc
Exchange NASDAQ | Headquaters Newburyport, MA, United States | ||
IPO Launch date 1993-12-16 | CEO & Chairman Mr. R. Jeffrey Bailly CPA | ||
Sector Healthcare | Industry Medical Devices | Full time employees 4146 | Website https://www.ufpt.com |
Full time employees 4146 | Website https://www.ufpt.com | ||
UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company offers protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and custom protective case systems for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. The company serves the medical, aerospace and defense, industrial, and automotive markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.